Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitol cell collections for autologous transplantation
A. Bashey et al., Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitol cell collections for autologous transplantation, CYTOTHERAPY, 2(3), 2000, pp. 195-200
Citations number
28
Categorie Soggetti
Hematology,"Medical Research Diagnosis & Treatment
Background
A proportion of candidates for high-dose chemotherapy with autologous PBPC
support (HDC-PBCS) will not provide an adequate PBPC yield from their first
mobilization. The value of re-mobilization. The value of re-mobilization a
nd the best regimen for re-mobilization in these patients is unclear.
Methods
In 23 patients who failed to provide greater than or equal to 3 X 10(6) CD3
4(+) cells/kg after their first mobilization, PBPC were re-mobilized using
a regimen of simultaneous administration of G-CSF and GM-CSF (10 mu g/kg/da
y each) with leukaphereses (LP) starting Day 4 or 5 of CSF administration.
Yields of WBC/kg, MNC/kg and CD34(+) cells/kg/L of processed blood were com
pared between the first and second mobilization in each patient. The abilit
y of the combined yield from the two mobilizations to achieve the desired t
hreshold PBPC yield and the tolerability of the re-mobilization were determ
ined.
Results
The re-mobilization regimen was well-tolerated and no patient discontinued
the regimen because of toxicity. Median collected WBC/kg/L (1.37 X 10(7) ve
rsus 2.62 X 10(7), p = 0.0065), MNC/kg/L (0.77 X 10(7) versus 1.97 X 10(7),
p = 0.0003), CD34(+) cells/kg/L (1.64 X 10(7) versus 1.97 X 10(7),p = 0.00
1) were significantly higher after the second mobilization (G-CSF/GM-CSF co
mbination). Percentage of CD34(+) cells in the leukapheresis was also signi
ficantly higher after the second mobilization (median 0.104% versus 0.195%,
p = 0.036). Twelve of 22 patients achieved the target PBPC dose (> 3 X 10(
6) /CD34(+)cells/kg) after two mobilizations (six patients achieved the tar
get from the second mobilization alone). A further eight underwent HDC-PBPC
S without achieving the target PBPC dose. These patients experienced a sign
ificant delay in neutrophil and platelet engraftment when compared with tho
se patients achieving the target dose.
Discussion
This study demonstrates that the combination of G-CSF and GM-CSF is an effe
ctive and tolerable method for re-mobilization of PBPC in patients who fail
to provide an adequate yield from their first mobilization.